Ex-Pharma CEO Says SEC Call For Banishment Too Harsh
The one-time leader of a drug company whose sole product was derived from goat's blood on Thursday asked an Illinois federal judge to deny the U.S. Securities and Exchange Commission's request...To view the full article, register now.
Already a subscriber? Click here to view full article